HKU Scholars Hub: Browsing DSpace

Browsing by Author Cheng, PNM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 13 of 13

	Title	Author(s)	Issue Date	Views
	A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients Journal:Investigational New Drugs	Yau, TCC Cheng, PNM Chiu, WYJ Kwok, GW Leung, RCY Liu, AM Cheung, TT Ng, CT	2021	17
	Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma Journal:Current Cancer Drug Targets	Chow, AKM Ng, L Li, HS Cheng, CW Lam, CSC Yau, TCC Cheng, PNM Fan, ST Poon, RTP Pang, RWC	2012	137
	Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition Journal:Scientific Reports	XU, S Lam, SK Cheng, PNM Ho, JCM	2019	28
	der(Y)t(Y;1) is a nonrandom abnormality in myelodysplastic syndrome [4] Journal:Cancer Genetics and Cytogenetics	Wei, DCC Wan, TSK Chan, LC Cheng, PNM	1993	179
	Endogenous arginase 2 as a biomarker for PEGylated arginase 1 treatment in squamous cell lung carcinoma xenograft models Proceeding/Conference:Journal of Clinical Oncology	Ho, JCM Xu, S Cheng, PNM Lam, SK	2018	47
	In vitro effects of pegylated arginase in small cell lung cancer Proceeding/Conference:Journal of Thoracic Oncology	Xu, S Lam, SK Cheng, PNM Ho, JCM	2016	40
	Inhibition of ornithine decarboxylase facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models Proceeding/Conference:Journal of Thoracic Oncology	Ho, JCM U, KP Xu, S Cheng, PNM Lam, SK	2017	62
	Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells Journal:Oxidative Medicine and Cellular Longevity	Zhao, Z Zhang, P Li, W Wang, D Ke, C Liu, Y Ho, JCM Cheng, PNM XU, S Editor(s):Quiles, JL	2021	12
	Pegylated recombinant human hepatic arginase I (rhArg-peg 5,000 mw) inhibits human hepatocellular carcinoma in vitro and in vivo Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma	Cheng, PNM Lo, T Leung, T Poon, RTP	2004	126
	Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest Journal:Cancer Letters	Lam, TL Wong, GKY Chong, HC Cheng, PNM Choi, SC Chow, TL Kwok, SY Poon, RTP Wheatley, DN Lo, WH Leung, YC	2009	205
	Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma	Cheng, PNM Leung, T Lo, T Poon, RTP	2004	97
	Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma ( Journal:Asian Journal of Surgery	Cheng, PNM Leung, T Lo, T Poon, RTP	2005	117
	Suppression of tumour growth by pegylated arginase in malignant pleural mesothelioma Proceeding/Conference:Journal of Thoracic Oncology	Ho, JCM U, KP Xu, S Cheng, PNM Lam, SK	2017	53

Showing results 1 to 13 of 13